NCT02544048View on ClinicalTrials.gov

Markers of T Cell Suppression: Antimalarial Treatment and Vaccine Responses in Healthy Malian Adults

CompletedOBSERVATIONAL
Enrollment

49

Participants

Timeline

Start Date

September 4, 2015

Primary Completion Date

September 4, 2015

Study Completion Date

August 11, 2017

Conditions
Malaria
Trial Locations (1)

Unknown

Malaria Research and Training Center, Bamako

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT02544048 - Markers of T Cell Suppression: Antimalarial Treatment and Vaccine Responses in Healthy Malian Adults | Biotech Hunter | Biotech Hunter